Patents by Inventor Gyorgy Nemeth

Gyorgy Nemeth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions with increased activity
    Patent number: 8048882
    Abstract: The invention relates to novel pharmaceutical combinations with improved sodium channel blocking effect. Further, the invention relates to the use of said pharmaceutical combinations in chronic pain, in disturbances of the motor system, in epilepsy, as well as in other therapeutic fields where the use of sodium channel blockers is acceptable.
    Type: Grant
    Filed: December 18, 2004
    Date of Patent: November 1, 2011
    Inventors: Pal Kocsis, Istvan Tarnawa, Marta Than, Karoly Tihanyi, Gyorgy Nemeth
  • PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING ACUTE MANIA
    Publication number: 20100197704
    Abstract: The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of acute mania. Furthermore, the present invention relates to the treatment of acute mania through the administration of (thio)-carbamoyl cyclohexane derivatives, particularly trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 19, 2008
    Publication date: August 5, 2010
    Inventors: Istvan Laszlovsky, Gyorgy Nemeth, Gyorgy Andor
  • (THIO) -CARBAMOYL-CYCLOHEXANE DERIVATIVES AND METHOD FOR TREATING SCHIZOPHRENIA
    Publication number: 20100197666
    Abstract: The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)-carbamoyl cyclohexane derivatives, particularly trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 19, 2008
    Publication date: August 5, 2010
    Inventors: Istvan Laszlovsky, Gyorgy Nemeth, Gyorgy Andor
  • Novel pharmaceutical compositions with increased activity
    Publication number: 20070129370
    Abstract: The invention relates to novel pharmaceutical combinations with improved sodium channel blocking effect. Further, the invention relates to the use of said pharmaceutical combinations in chronic pain, in disturbances of the motor system, in epilepsy, as well as in other therapeutic fields where the use of sodium channel blockers is acceptable.
    Type: Application
    Filed: December 18, 2004
    Publication date: June 7, 2007
    Inventors: Pal Kocsis, Istvan Tamawa, Marta Than, Karoly Tihanyi, Gyorgy Nemeth